{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:26:51Z","timestamp":1789590411954,"version":"build-2803163510"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>We focus on the role of killer immunoglobulin receptor (KIR) interactions with the human leukocyte antigens (HLA)-B27 ligand and the potential contribution of KIR-expressing natural killer and T cells in spondyloarthritis, more specifically in ankylosing spondylitis (AS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>In AS strong epidemiological evidence of significant genetic associations with the major histocompatibility complex was convincingly identified. HLA-B27-positive first-degree relatives of AS cases are 5\u201316 times more likely to develop disease than HLA-B27-positive carriers in the general community. The GWAS era has enabled rapid progress in identifying non-major histocompatibility complex associations of AS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>These findings show a number of important pathways in AS pathogenesis, including the IL-23\u2013IL-17 pathway, aminopeptidases, peptide presentation, and KIR\u2013HLA-B27 interactions. Studies using genetic markers, including KIRs may be used for a risk assessment about whom may benefit most from the various treatment protocols in spondyloarthritis, now that alternative therapeutic options have become feasible.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000302","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T11:34:21Z","timestamp":1463052861000},"page":"368-375","source":"Crossref","is-referenced-by-count":9,"title":["Killer immunoglobulin receptor genes in spondyloarthritis"],"prefix":"10.1097","volume":"28","author":[{"given":"Taco W.","family":"Kuijpers","sequence":"first","affiliation":[{"name":"Sanquin, Department of Blood Cell Research and Landsteiner Laboratory of Immunology"},{"name":"Department of Pediatric Hematology, Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Vendelbosch","sequence":"additional","affiliation":[{"name":"Sanquin, Department of Blood Cell Research and Landsteiner Laboratory of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlijn van den","family":"Berg","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique L.P.","family":"Baeten","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.immuni.2005.01.013","article-title":"A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells","volume":"22","author":"Freud","year":"2005","journal-title":"Immunity"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/icb.2009.94","article-title":"A potential role for RAG-1 in NK cell development revealed by analysis of NK cells during ontogeny","volume":"88","author":"Andrews","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nri3044","article-title":"NK cell development, homeostasis and function: parallels with CD8+ T cells","volume":"11","author":"Sun","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2005.10.001","article-title":"Human natural killer cell development and biology","volume":"20","author":"Farag","year":"2006","journal-title":"Blood Rev"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/icb.2010.78","article-title":"Activating and inhibitory receptors of natural killer cells","volume":"89","author":"Pegram","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.0001-2815.2004.00290.x","article-title":"The LILR family: modulators of innate and adaptive immune pathways in health and disease","volume":"64","author":"Brown","year":"2004","journal-title":"Tissue Antigens"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","article-title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education","volume":"116","author":"Bj\u00f6rkstr\u00f6m","year":"2010","journal-title":"Blood"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.4049\/jimmunol.180.6.3739","article-title":"CD27 defines phenotypically and functionally different human NK cell subsets","volume":"180","author":"Vossen","year":"2008","journal-title":"J Immunol"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-015-0507-2","article-title":"IL-23 responsive innate-like T cells in spondyloarthritis: the less frequent they are, the more vital they appear","volume":"17","author":"Venken","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.39261","article-title":"Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid","volume":"67","author":"Leijten","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells-a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coi.2016.01.007","article-title":"Development and maturation of natural killer cells","volume":"39","author":"Geiger","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2010.08.031","article-title":"Natural killer cell education and tolerance","volume":"142","author":"Orr","year":"2010","journal-title":"Cell"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1590\/S0021-75572008000500009","article-title":"Natural killer cells and immune surveillance","volume":"84","author":"Jobim","year":"2008","journal-title":"J Pediatr"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"ii:a007229","DOI":"10.1101\/cshperspect.a007229","article-title":"Natural killer cell tolerance: control by self or self-control?","volume":"4","author":"Jaeger","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1084\/jem.20100762","article-title":"Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus","volume":"208","author":"Bj\u00f6rkstr\u00f6m","year":"2011","journal-title":"J Exp Med"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Gum\u00e1","year":"2004","journal-title":"Blood"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2012-10-459545","article-title":"NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs","volume":"121","author":"B\u00e9ziat","year":"2013","journal-title":"Blood"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1034\/j.1600-065X.2001.1810102.x","article-title":"The genomic context of natural killer receptor extended gene families","volume":"181","author":"Trowsdale","year":"2001","journal-title":"Immunol Rev"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80394-5","article-title":"Human diversity in killer cell inhibitory receptor genes","volume":"7","author":"Uhrberg","year":"1997","journal-title":"Immunity"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"MHC class I molecules and KIRs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"e67619","DOI":"10.1371\/journal.pone.0067619","article-title":"Extensive variation in gene copy number at the killer immunoglobulin-like receptor locus in humans","volume":"8","author":"Vendelbosch","year":"2013","journal-title":"PLoS One"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/hmg\/ddp538","article-title":"Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex","volume":"19","author":"Traherne","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/gene.2014.68","article-title":"Intergenic regions and hot-spots of recombination at the human killer immunoglobulin-like receptor (KIR) locus","volume":"16","author":"Vendelbosch","year":"2015","journal-title":"Genes Immun"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.smim.2008.06.003","article-title":"The Yin and Yang of HLA and KIR in human disease","volume":"20","author":"Kulkarni","year":"2008","journal-title":"Sem Immunol"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.4161\/cbt.8.23.10455","article-title":"Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR)","volume":"8","author":"Purdy","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20021127","article-title":"DNA methylation maintains allele-specific kir gene expression in human natural killer cells","volume":"197","author":"Chan","year":"2003","journal-title":"J Exp Med"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.molimm.2004.07.029","article-title":"Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation","volume":"42","author":"Uhrberg","year":"2005","journal-title":"Mol Immunol"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1038\/sj.onc.1205599","article-title":"Gene silencing in mammalian cells and the spread of DNA methylation","volume":"21","author":"Turker","year":"2002","journal-title":"Oncogene"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4049\/jimmunol.180.1.418","article-title":"Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hematopoietic progenitor to NK Cells","volume":"180","author":"Santourlidis","year":"2008","journal-title":"J Immunol"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1182\/blood-2012-10-461442","article-title":"Influence of KIR gene copy number on natural killer cell education","volume":"121","author":"B\u00e9ziat","year":"2013","journal-title":"Blood"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"e1000254","DOI":"10.1371\/journal.pgen.1000254","article-title":"Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression","volume":"4","author":"Li","year":"2008","journal-title":"PLoS Genet"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00251-010-0449-9","article-title":"Differential RNA expression of KIR alleles","volume":"62","author":"McErlean","year":"2010","journal-title":"Immunogenet"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.humimm.2006.12.007","article-title":"Studies on the expression of the deleted KIR2DS4\u2217003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations","volume":"68","author":"Middleton","year":"2007","journal-title":"Hum Immunol"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.4049\/jimmunol.171.12.6640","article-title":"The protein made from a common allele of KIR3DL1 (3DL1\u2217004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1","volume":"171","author":"Pando","year":"2003","journal-title":"J Immunol"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1002\/art.21395","article-title":"Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis","volume":"52","author":"Chan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.4049\/jimmunol.173.3.1819","article-title":"MHC class I-independent recognition of NK-activating receptor KIR2DS4","volume":"173","author":"Katz","year":"2004","journal-title":"J Immunol"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.189.7.1093","article-title":"A human Histocompatibility Leukocyte Antigen (HLA)-G-specific receptor expressed on all natural killer cells","volume":"189","author":"Rajagopalan","year":"1999","journal-title":"J Exp Med"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fimmu.2013.00008","article-title":"Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms","volume":"4","author":"K\u00fasnierczyk","year":"2013","journal-title":"Front Immunol"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/ar4232","article-title":"Natural killer cells in human autoimmune disorders","volume":"15","author":"Fogel","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.humimm.2014.05.014","article-title":"Associations of killer cell immunoglobulin like receptors with rheumatoid arthritis among North Indian population","volume":"75","author":"Prakash","year":"2014","journal-title":"Hum Immunol"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1155\/2012\/486320","article-title":"Associations of killer cell immunoglobulin-like receptor genes with rheumatoid arthritis","volume":"33","author":"Ram\u00edrez-De los Santos","year":"2012","journal-title":"Dis Markers"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2337\/diabetes.52.10.2639","article-title":"KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects","volume":"52","author":"van der Slik","year":"2003","journal-title":"Diabetes"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/ard.2005.041103","article-title":"Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis","volume":"65","author":"Jaakkola","year":"2006","journal-title":"Ann Rheumat Dis"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat Genet"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/tan.12563","article-title":"KIR3DL1 and KIR3DL2 gene copy number variation in axial spondyloarthritis","volume":"85","author":"Vendelbosch","year":"2015","journal-title":"Tissue Antigens"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/art.39288","article-title":"Study on the protective effect of the KIR3DL1 gene in ankylosing spondylitis","volume":"67","author":"Vendelbosch","year":"2015","journal-title":"Arthritis Rheum"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","article-title":"Association scan of 14\u200a500 nonsynonymous SNPs in four diseases identifies autoimmunity variants","volume":"39","author":"Burton","year":"2007","journal-title":"Nat Genet"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","article-title":"Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility","volume":"43","author":"Evans","year":"2011","journal-title":"Nat Genet"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/bi201230p","article-title":"The crystal structure of human endoplasmic reticulum aminopeptidase 2 reveals the atomic basis for distinct roles in antigen processing","volume":"51","author":"Birtley","year":"2012","journal-title":"Biochemistry"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1038\/ncomms8146","article-title":"Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1","volume":"6","author":"Cortes","year":"2015","journal-title":"Nat Commun"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4049\/jimmunol.1003986","article-title":"IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass","volume":"187","author":"Adamopoulos","year":"2011","journal-title":"J Immunol"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammaT+ CD3+ CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","article-title":"Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response","volume":"13","author":"Appel","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.37937","article-title":"In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis","volume":"65","author":"Appel","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.33396","article-title":"Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis","volume":"64","author":"Noordenbos","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.24389","article-title":"Overexpression ofinterleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis","volume":"60","author":"Ciccia","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","article-title":"Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis","volume":"373","author":"Mease","year":"2015","journal-title":"N Engl J Med"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","article-title":"Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis","volume":"186","author":"Bowness","year":"2011","journal-title":"J Immunol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201607000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T06:35:15Z","timestamp":1693290915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201607000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000302","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}